Document is current
Any future updates will be listed below
-
Authors
Schuster, Emma
Dashzeveg, Nurmaa K. https://orcid.org/0000-0002-6702-5187
Tong, Fangjia
Jia, Yuzhi
El-Shennawy, Lamiaa
Zhang, Tong
Hoffman, Andrew D.
Kitata, Reta Birhanu https://orcid.org/0000-0002-8973-7679
Kibria, Golam
Zhang, Youbin
Squires, Joshua R.
Zheng, Chunlei
Ramos, Erika
Taftaf, Rokana
Scholten, David
Almubarak, Hannah F. https://orcid.org/0000-0001-5895-9968
Adorno-Cruz, Valery
Sullivan, David P. https://orcid.org/0000-0002-7462-3898
Reduzzi, Carolina https://orcid.org/0000-0003-0514-0152
Minor, Allegra C. https://orcid.org/0009-0006-5984-1762
Purev-Ochir, William
Spahija, Sabina
Xu, Rong https://orcid.org/0000-0003-3127-4795
Siziopikou, Kalliopi P.
Platanias, Leonidas C. https://orcid.org/0000-0002-9740-7573
Shah, Ami
Muller, William A. https://orcid.org/0000-0002-4802-2757
Gradishar, William J. https://orcid.org/0000-0002-2772-3140
Cristofanilli, Massimo
Tsai, Chia-Feng
Shi, Tujin https://orcid.org/0000-0002-5592-3588
Liu, Huiping https://orcid.org/0000-0003-4822-7995
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA245699)
- License Information
-
More Information
Article History
Received: 21 February 2025
Accepted: 2 August 2025
First Online: 16 August 2025
Competing interests
: Huiping Liu and Andrew D. Hoffmann are scientific co-founders and equity shareholders of ExoMira Medicine Inc., whose business is not currently related to the content of this manuscript. Massimo Cristofanilli has the following financial relationships to disclose: (1) serving as consultant for AZ, Celcuity, Menarini-Stemline, Repare Therapeutics, Olaris, Syantra, BriaCell, Datar Cancer Genomics, Biotheryx; (2) received grant or research support from AZ, Celcuity; (3) received honoraria from AZ, Merck, Iylon, Menarini-Silicon Biosystem, Datar Cancer Genomics; and (4) participated in Speaker Bureau of Pfizer. Carolina Reduzzi receives research support from Menarini Silicon Biosystems, ANGLE, Qiagen, BioRad, Tethis. The remaining authors declare no competing interests.
